Skip to main content

Find Clinical Trials

Home
Conditions
Liver Neoplasms

Clinical trial condition

Liver Neoplasms

Explore clinical trials studying Liver Neoplasms. Study availability and eligibility vary by location and protocol.

1,743 public trials 464 recruiting studies

Refine in advanced search Browse all conditions

Liver Neoplasms trial results

Not Yet Recruiting

Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus

NCT07363512

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prediction of Complications in Hepatic Tumors

NCT07358975

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Rigshospitalet Copenhagen, Denmark

View Trial Details

Not Yet Recruiting

Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma

NCT07356037

Conditions: Adenocarcinoma, Body Weight, Body Weight Changes, +16 more
Locations: West China School of Medicine/West China Hospital of Sichuan University Chengdu, Sichuan, China

View Trial Details

Not Yet Recruiting

Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma

NCT07352345

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Wuhan union hosptital Wuhan, Hubei, China

View Trial Details

Not Yet Recruiting

FAD Subtype-Guided Combination Therapy for Unresectable Hepatocellular Carcinoma

NCT07314372

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

SARS-CoV-2 mRNA Vaccination in Patients With Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors

NCT07341321

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +11 more
Locations: Medical University of Graz Graz, Austria

Ordensklinikum Linz Linz, Austria

University Hospital St. Pölten Sankt Pölten, Austria

Krankenhaus der Barmherzigen Brüder St Veit an der Glan Sankt Veit an der Glan, Austria

View Trial Details

Not Yet Recruiting

A Trial of Behavioral Intervention on Prognostic Survival of Patients With Unresectable Liver Cancer

NCT07337031

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Eastern Hepatobiliary Surgery Hospital Shanghai, China

View Trial Details

Not Yet Recruiting

Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With Acquired Resistance to Immune Checkpoint Therapy: A Single-Arm Exploratory Clinical Study

NCT07324473

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China

View Trial Details

Not Yet Recruiting

A Phase III Randomized Study of TACE Plus an Oral Triple-Agent Cocktail Versus TACE Plus First-Line Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

NCT07309419

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Retrospective Study of Safety and Efficacy of Locoregional Therapies Combined With Anti-VEGF/TKIs and Immune Checkpoint Inhibitors for All Comers of Intention-to-treat Patients With Hepatocellular Carcinoma Beyond UCSF Criteria Before Liver Transplantation

NCT07310836

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Not specified

View Trial Details